WE MAKE AQUACULTURE PROGRESS
Vietnam and Norway exchanged inspiration to support sustainable growth in the Pangasius industry
Oslo, May 25th 2019, the Vietnamese Prime Minister Nguyen Xuan Phuc seeked inspiration from PHARMAQ part of Zoetis when looking into growing the aquaculture industry in Vietnam.
Saturday May 25th , the Vietnamese Prime Minister visited PHARMAQ’s global R&D center in Oslo, Norway, to discuss how to support sustainable growth and reduce the need for antibiotics in farming of Pangasius.
PHARMAQ has been an important partner and supplier of fish vaccines to the Norwegian salmon industry from the early 1990s contributing to the elimination of the use of antibiotics in Norwegian aquaculture. For the last ten years the company has been collaborating with the Vietnamese government, the aquaculture industry and academia to reduce the need for antibiotics in Pangasius farming.
“Within the last two years we have vaccinated more than 80 million Pangasius in Vietnam, preventing disease caused by the bacteria Edwardsiella ictaluri and Aeromonas hydrophila and reducing the need for antibiotic treatments. Having Prime Minister Phuc here to visit gave us a unique opportunity to strengthen our shared ambition for sustainable growth in the Vietnamese aquaculture industry,” says Morten Nordstad President of PHARMAQ.
As part of the visit to PHARMAQ, the Vietnamese delegation were given a tour of the R&D laboratory and met with PHARMAQ scientists as well as company executives. The delegation’s aim is to stimulate the collaboration between Vietnamese and Norwegian companies, in order to introduce new technologies and facilitate sustainable growth in Vietnam.
For further information, please contact:
President PHARMAQ a business of Zoetis
Mobile: +47 907 52 853
PHARMAQ is the global leader in fish health and vaccines, dedicated to support sustainable growth in the aquaculture industry. PHARMAQ is part of Zoetis, the world leader in animal health. Our innovative fish health solutions include PHARMAQ fish vaccines and therapeutics, PHARMAQ Fishteq vaccination machinery, and PHARMAQ Analytiq research and analysis. PHARMAQ’s research and production facilities are based in Norway, with global operations in commercial fish farming markets. PHARMAQ has 300 employees. We invest in our people and offer opportunities to make a difference in a growing aquaculture industry. To learn more, visit PHARMAQ.com and Zoetis.com.
About PHARMAQ in Vietnam
PHARMAQ a long-term commitment to the aquaculture industry in Vietnam and has been present in the country for more than 10 years. The main office in situated in Ho Chi Minh City. As part of PHARMAQ’s long term strategy and commitment to the Vietnamese aquaculture industry, a new modern R&D- and diagnostic laboratory was built and opened in Can Thô in 2018. In addition, a Wet laboratory for clinical testing located in Hồng Ngự. PHARMAQ Vietnam has 14 dedicated employees and is an integrated part of local Zoetis organisation.
Did you know...
Newsfeed delivered by Meltwater News. PHARMAQ is not to be held liable for any of its content nor possible incorrect information given.
Pharmaq produserer vaksiner til 70 prosent av verdens laks
Europe Fish Vaccine Market 2020 Research on Import-Export Details, Business Standards and Forecast to 2025
Pharmaq recibe autorización para comercialización de nueva vacuna
Farmed Salmon is a Core Component of Healthy, Sustainable Diets
Har fått markedsføringstillatelse til ny vaksine - Kyst.no
Global Deltamethrin Market Analysis, Revenue, Share, Size, Developments, Feasibility Check
I denne bygda produserer de vaksiner til 70 prosent av verdens laks
FDA awards grants to help fund MUMS research
How Impact of Covid-19 on Single Drum Friability Testers market Development is Changing Business Needs?
Veterinary Vaccines Market : Facts, Figures and Analytical Insights 2020